Stock listing
Pasithea Therapeutics Corp.
Selected listing: KTTA · NASDAQ · USD · US
Pasithea Therapeutics Corp. (NASDAQ:KTTA), Health Technology. Latest release Sep 14, 2026: Pasithea Therapeutics Announces Presentation of Initial PAS-004…
- Ticker
- NASDAQ:KTTA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. is a public company traded under the ticker KTTA in the American market. Pasithea focuses on developing innovative therapies, although specific details about its products or services are not provided.
Latest news from Pasithea Therapeutics Corp.
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
September 14, 2026
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
September 3, 2026
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
July 21, 2026
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
July 8, 2026
Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion
June 30, 2026
Research Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. company profile
View the public company page for Pasithea Therapeutics Corp. on 6ix.
Pasithea Therapeutics Corp. news
Read company news and market updates connected to Pasithea Therapeutics Corp..
Pasithea Therapeutics Corp. investor events
Find investor webinars, events, and replay context for Pasithea Therapeutics Corp..